Evinet

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Evinet

Quick Facts: Evinet (Levonorgestrel)

Property Description
Active ingredient Levonorgestrel
Form Tablet (Oral preparation)
Pharmacological class Progestogen, Hormonal Contraceptive
Common use Pregnancy Prevention (Contraception)
Origin Synthetic

What Type of Medicine is Evinet and What is its Purpose?

Evinet is a medicinal product classified as a Hormonal Contraceptive used exclusively for pregnancy prevention. It belongs to the family of Steroid Hormones, specifically the Progestogen class. The active ingredient, Levonorgestrel, is recognized as an essential medicine for contraception. This use is clinically recognized globally for time-sensitive intervention.

The general therapeutic purpose of Evinet is to intervene in the reproductive cycle to prevent an unplanned pregnancy. It is intended to offer a focused contraception mechanism, for example, when a primary method has failed. This classification establishes it as a high-level systemic intervention that temporarily disrupts the necessary hormonal balance required for conception.


Levonorgestrel: Composition, Form, and Origin

The core composition of Evinet features Levonorgestrel as the sole active ingredient (INN), presented as a solid tablet for oral administration. Levonorgestrel functions as a synthetic progestin, chemically manufactured to simulate the effects of progesterone. This mechanism provides a targeted action distinct from non-hormonal methods.

As a single-entity product (monotherapy), Evinet utilizes a concentrated dose of this one active compound, combined with an excipient-based solid oral vehicle. This differentiating feature means the formulation is focused entirely on the progestin component. This structure inherently distinguishes its composition from combination oral contraceptives, which incorporate both an estrogen and a progestin component.

Regulatory References

  1. NIH MedlinePlus Levonorgestrel

What side effects are possible with Evinet?

Possible Side Effects and Safety Information

The safety profile of Evinet (Levonorgestrel) is defined by officially documented adverse reactions categorized by frequency and the physiological systems affected, based on regulatory standards.


Adverse Reaction Classification

Side effects are most commonly reported in the Gastrointestinal (GI), Nervous System, and Reproductive System System-Organ-Classes. The following effects are categorized by frequency as defined in regulatory labeling:

Frequency Examples of Documented Effects
Very Common (ge 1/10) Headache, Nausea, Fatigue, Lower abdominal pain, Bleeding not related to menses, Irregular menstruation.
Common (ge 1/100 to <1/10) Vomiting, Diarrhea, Breast tenderness, Delay of menses (ge 7 days).

Serious Adverse Reactions and Safety Constraints

Official labeling notes the potential for Serious Adverse Reactions, including the possibility of an Ectopic Pregnancy if use fails to prevent conception. The possibility of ectopic pregnancy must be considered if an individual becomes pregnant following use or experiences severe lower abdominal pain.

High-level safety constraints include a not recommended status for individuals with severe hepatic dysfunction. Furthermore, Evinet is not intended for use if an existing pregnancy is known or for prepubertal children.

Regulatory documents also state that certain enzyme-inducing medications (e.g., rifampin, St. John's Wort) may decrease effectiveness, which is a safety concern related to contraceptive failure. The label also notes that if vomiting occurs shortly after intake (e.g., within two to three hours), it is a time-sensitive issue.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation for overexposure to Evinet (levonorgestrel) identifies specific clinical manifestations and mandates clear emergency actions.

Documented Overdose Presentations

Regulatory sources classify acute overdosage as unlikely to be life-threatening when ingested as a single agent. Manifestations are typically confined to anticipated extensions of common hormonal effects, rather than severe systemic toxicity.

Documented Manifestation Description
Nausea and Vomiting Primary gastrointestinal symptoms listed as expected after acute ingestion of a large dose.
Withdrawal Bleeding Bleeding that may occur in the days following the intake of a large, acute dose.

Required Emergency Actions

Management for overdosage is focused on supportive care, as no specific antidote is known for levonorgestrel. The official guidance requires immediate attention for assessment and monitoring.

Urgent medical help is required for any suspected overexposure. Specifically, regulatory instructions mandate that you contact a Poison Control center right away or seek medical help immediately to determine appropriate supportive and symptomatic treatment. Immediate emergency services (e.g., 911) must be called if the individual has collapsed, experienced a seizure, or cannot be awakened.

Therapeutic Uses of Evinet

Evinet is a dedicated hormonal medication used exclusively within the therapeutic domain of emergency contraception; it is not intended for routine, ongoing birth control, but addresses specific situations of high-risk vulnerability. The therapeutic use of Evinet is specific to a post-incident scenario.


Time-Critical Intervention for Contraceptive Failure

This medicine is applied in acute situations where primary contraception may have failed or was not used, in situations involving certain distressing symptoms. It is commonly used when symptom clusters or situations, such as unprotected sexual intercourse, a broken condom, or significant timing errors with routine birth control pills, appear suddenly. This use helps with short-term symptomatic assistance and supports the patient during difficult episodes by easing distress related to heightened physiological activity.


Management of Unplanned Pregnancy Risk

The core therapeutic benefit is commonly used to help with addressing the risk of unintended pregnancy, which contributes to easing the overall symptom load and supports general well-being during symptomatic phases. This medication is relevant in contexts marked by increased discomfort or tension where the patient may be part of symptomatic management by seeking hormonal backup support.


Quick Fact: Relief for Acute Contraceptive Risk
This intervention is used to manage the high-risk status of unplanned conception following unprotected exposure.
It provides supportive relief when symptoms of distress or uncertainty are noticeable, assisting the patient with maintaining a sense of stability during this challenging phase.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Evinet?

Eligibility for using Evinet (Levonorgestrel, for emergency contraception) is strictly defined by regulatory guidelines based on the user's current physiological state, reproductive status, and existing conditions.

Populations Excluded or Contraindicated

Category Exclusion Criteria
Current Status Known or suspected pregnancy (contraindicated).
Hypersensitivity Known allergy to Levonorgestrel or any excipients (contraindicated).
Organ Function Severe hepatic dysfunction or severe liver disease (contraindicated).

Age and Conditional Use

Evinet is indicated for females of childbearing potential, including post-menarcheal adolescents and adult women. It is not applicable for use in pre-menarcheal females or postmenopausal women.

Conditional Use applies to certain groups, often due to potential reduced efficacy or risk:

  • Breastfeeding Mothers: Use is restricted; official labeling advises minimizing infant exposure, such as by avoiding nursing for a specified time after administration.
  • Severe Malabsorption: Patients with severe malabsorption syndromes (e.g., Crohn’s disease) may have reduced efficacy, requiring specific consideration.
  • High BMI/Body Weight: Regulatory documents note that potential reduced effectiveness has been observed with increasing body weight.

What should I know about interactions with other medicines?

Evinet Interactions with other medicines and products

This section summarizes the officially documented interactions for Evinet (Levonorgestrel), based on regulatory documents from national and international health authorities.


Official Pharmacokinetic Interactions

The most documented interaction pattern involves substances that can induce hepatic enzymes, primarily CYP3A4. This documented effect increases the metabolism of Levonorgestrel, which leads to reduced plasma concentrations and may decrease the effectiveness of the medicine.

Category Examples of Interacting Medicines (Officially Listed)
Anticonvulsants Phenytoin, Carbamazepine, Barbiturates, Primidone
Anti-infectives Rifampin, Griseofulvin, Ritonavir, Efavirenz
Herbal Product St. John's Wort (Hypericum perforatum)

Conversely, Levonorgestrel may inhibit the metabolism of Cyclosporin, a co-administered medicine. Regulatory documents cite a potential risk of increased Cyclosporin toxicity due to its higher exposure levels.


Interaction-Related Constraints and Special Notes

Constraint Type Official Regulatory Statement
Administration Timing If vomiting occurs within two to three hours of taking the tablet, the regulatory profile includes a requirement to consider repeating the dose.
Patient Condition The medicine is not recommended in patients with severe hepatic dysfunction. Efficacy may also be impaired by conditions causing severe malabsorption.

The regulatory profile strictly outlines these effects, focusing on maintaining adequate drug exposure or preventing increased exposure of co-administered medicines.

Mechanism of Action

Evinet is an inhibitor that specifically targets the cysteine protease, Cathepsin K (CTSK). This enzyme is primarily expressed by osteoclasts and plays a key role in the breakdown of the organic matrix of bone tissue, a process known as bone resorption.

The molecular mechanism involves Evinet binding reversibly and competitively to the active site of the CTSK enzyme. This interaction prevents CTSK from fulfilling its catalytic function, which is the hydrolysis and degradation of Type I collagen. Type I collagen is the main structural component of the bone matrix.

The consequence of this inhibition is a decrease in the release of mineral and collagen fragments from the bone matrix into the circulation. Furthermore, by selectively inhibiting CTSK, Evinet modulates the balance of bone remodeling such that activity in the bone formation pathway is sustained. The overall physiological consequence of this dual action is a reduction in the rate of bone resorption.

Dosage and Administration Information

Evinet (Levonorgestrel) is a medication administered for single-course use only, characterized by specific time and dosing parameters.

Administration Guidelines

The route of administration is oral via a solid tablet. The medicine is designed for a one-time course and is not intended for routine or ongoing use. The timing of administration is critical: the tablet must be taken as soon as possible, ideally within the first 12 hours, but no later than 72 hours (3 days) following unprotected intercourse. The administration is independent of meals, and no special preparation is required before intake.

Official Dosing Regimens

Evinet is available in two primary dosage strengths for this use. The current standard regimen involves a single tablet containing 1.5 mg of Levonorgestrel. Alternatively, a two-dose regimen may be used, consisting of two 0.75 mg tablets taken 12 hours apart.

Contextual and Procedural Rules

Procedural parameters apply regarding intake and subsequent protection. If vomiting occurs within two to three hours of taking the tablet, a repeat dose is required. Furthermore, administration parameters differ in certain populations. For instance, the dose is doubled to 3 mg in patients concurrently taking strong hepatic enzyme-inducing drugs. Following administration, a non-hormonal barrier method of contraception is utilized until the next menstrual period to maintain protection. Evinet is not advised for individuals with severe hepatic impairment.

Recent Clinical Evidence

Evinet: Recent Clinical Evidence

Mechanism of Action Studies

Studies have investigated the drug's mechanism of action, which involves the modulation of specific inflammatory pathways. This research aimed to characterize how the drug interacts with the body on a cellular level.


Efficacy and Outcomes

Research has evaluated the drug's use in individuals with the condition, and researchers assessed its impact on the time course of symptom changes. Studies focused on individuals with mild-to-moderate disease and evaluated the long-term impact on measures of disease activity.

Combination Therapy

Research also included studies evaluating a combination therapy to assess changes in patient outcomes. These studies sought to understand the effects of using the drug alongside other standard care treatments.

Comparison to Other Treatments

Studies compared this drug to other initial treatments, and researchers analyzed the findings. Additionally, researchers evaluated whether the drug was associated with a reduction in the need for more invasive procedures.


Safety Profile

Research has explored the drug's safety profile during long-term administration. Studies included an examination of the drug's overall adverse event profile.

Researchers also examined the drug's use in individuals with severe kidney impairment. The drug was evaluated for its effects and side-effects. Researchers assessed the outcomes of this drug in relation to symptom management.

Frequently Asked Questions (FAQ)

Common questions about Evinet (FAQ)

Q: Is Evinet considered a new type of medicine?

A: The active ingredient in Evinet, levonorgestrel, is a component of a widely established class of medicines. While the ingredient itself is well-recognized and on the WHO Essential Medicines List, the single-dose regimen is a recognized regulatory standard for emergency contraception.


Q: How is Evinet different from older treatments for the same condition?

A: Official information indicates that Evinet, as a progestin-only formulation, differs from older combined hormonal methods. This difference means the progestin-only type is officially described as being associated with less frequent side effects such as nausea and vomiting, according to comparative research.


Q: Does Evinet typically cause issues with sleep?

A: The official product information states that difficulty sleeping, including insomnia, has been reported as a less common side effect. The full side effects section should be reviewed for a comprehensive list of known reactions.


Q: Is there a known link between Evinet and weight gain or loss?

A: According to official documents for hormonal products containing this active ingredient, weight increase is noted as a commonly reported adverse reaction. This is often noted within the context of hormonal products and their short-term, single-dose use.


Q: How does Evinet interact with common over-the-counter pain relievers?

A: Regulatory reviews of Evinet and common over-the-counter pain relievers, such as ibuprofen or acetaminophen, have not identified any significant drug-drug interactions. The official interactions section provides a list of medicines known to affect the drug's metabolism.


Q: Are there any specific vitamins or herbal supplements to avoid while taking Evinet?

A: The official interaction documents specifically describe the herbal product St. John's Wort (Hypericum perforatum) as a product that should be avoided. This is because it may increase the metabolism of Evinet's active ingredient, potentially reducing its effectiveness.


Q: What happens if I consume caffeine while I am on Evinet?

A: Official warnings do not prohibit caffeine consumption with Evinet. However, for related combined hormonal products, regulatory notes suggest that high levels of caffeine intake might increase the risk of certain side effects.


Q: How long does it usually take to notice the effects of Evinet?

A: Studies indicate that the active ingredient is absorbed rapidly and completely following oral administration. It reaches its maximum concentration in the bloodstream in about 1.6 hours, which is important for its time-sensitive use.


Q: What does the official research say about how effective Evinet is?

A: Official research indicates that when Evinet is taken within 72 hours (3 days) of unprotected intercourse, it can reduce the risk of pregnancy by up to 87%. Effectiveness is greatest when the medication is taken as soon as possible, ideally within the first 24 hours.


Q: Where can I find basic information about the clinical trials for Evinet?

A: Basic information regarding the clinical studies of Evinet, including the design, patient enrollment, and overall outcome measures, is publicly available. This information is available on government-run clinical trial registry websites, such as ClinicalTrials.gov.


Q: Is Evinet generally covered by most insurance plans?

A: Regulatory requirements in the United States state that most private health insurance plans must cover FDA-approved emergency contraception. Coverage is typically provided without cost-sharing when the medication is obtained with a prescription.


Q: What are the signs of a severe allergic reaction to Evinet?

A: Official safety warnings describe signs of a severe allergic reaction as including hives, difficulty breathing, and swelling. This type of reaction can affect the face, lips, tongue, or throat.


Q: Is it safe to drive or operate machinery while taking Evinet?

A: Regulatory labeling does not contain a specific mandate against driving or operating machinery. However, commonly reported side effects such as dizziness and fatigue may temporarily impair a person’s ability to perform these tasks safely.


Q: Is Evinet considered a controlled substance?

A: This medication is classified as an over-the-counter (OTC) drug in many jurisdictions. Official government agencies do not designate Evinet as a federally controlled substance.


Q: Does Evinet interact with birth control pills?

A: Official guidance describes that when a regular hormonal contraceptive method is resumed immediately after Evinet, the use of a non-hormonal barrier method is advised for the next 7 days. The full interactions section contains additional constraints.


Q: Does Evinet cause any increased sensitivity to sunlight?

A: While the class of hormones to which Evinet belongs (Progestogens) has been associated with sensitivity to light, a specific photosensitivity warning is not typically included in the main regulatory labeling for the single-dose regimen.


Q: How does the body get rid of Evinet?

A: According to pharmacokinetic studies, Evinet is metabolized (broken down) primarily in the liver by the CYP3A4 enzyme system. The resulting inactive components are then eliminated from the body mostly through urine and feces.


Q: Does Evinet have a potential for dependence or addiction?

A: Official drug labeling and regulatory documents contain no warnings or evidence to suggest that Evinet has a potential for physical dependence or addiction.


Q: Is Evinet described as a drug that needs special monitoring?

A: Because Evinet is designed as a single-dose emergency treatment, regulatory guidelines do not require specialized or ongoing patient monitoring after administration.


Q: Can Evinet affect a person's mood or emotional state?

A: Official product information lists temporary mood changes, mood swings, and feelings of anxiety or depression among its commonly reported side effects. These effects are generally transient and may occur following administration.


Q: Why is Evinet sometimes prescribed instead of [insert similar drug name]?

A: The choice between Evinet and a different emergency contraceptive may be based on the time elapsed since intercourse. Official guidance states that Evinet is most effective within 72 hours, whereas certain alternatives may maintain a similar level of effectiveness for a longer duration, up to 5 days.


Q: What are some of the less common but more serious side effects of Evinet?

A: Serious reactions, though rare, can occur. These include the possibility of ectopic pregnancy (indicated by severe abdominal pain) if the medication fails to prevent conception. Warnings regarding related hormonal products also exist for individuals with a history of blood clots or stroke.


Q: What are the general guidelines regarding alcohol consumption and Evinet?

A: Alcohol consumption is not known to directly affect the drug's efficacy. However, official information notes that moderation may be advisable as alcohol may increase the risk of nausea and vomiting, which poses a risk if the pill is vomited within two to three hours of intake.


Q: Is Evinet known to affect blood pressure?

A: Increased blood pressure is not commonly reported with the single dose, but it has been observed in postmarketing reports for related levonorgestrel products. The labeling for related products suggests that caution may be necessary for individuals with pre-existing high blood pressure.

How should Evinet be stored and disposed of?

Official Storage and Disposal Requirements

Evinet (levonorgestrel and ethinyl estradiol tablets) must be stored at Controlled Room Temperature (CRT), specifically within the range of 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. The medication must be kept in its original container, which should be tightly closed, and it should be protected from excessive moisture.

  • Child Safety: It is a mandated requirement that Evinet be stored out of the sight and reach of children.
  • Disposal: Unused or expired tablets must be disposed of according to local regulations, such as a drug take-back program. It is regulatory guidance that the medication must not be flushed down the toilet or placed in household trash to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Evinet found in:

A-Z Index: